Name: "Anti-FR1 (HuMov19) h(CD28-OX40-CD3_) CAR, pCDCAR1"
Availability: InStock

"Anti-FR1 (HuMov19) h(CD28-OX40-CD3_) CAR, pCDCAR1" | Creative Biolabs

Creative biolabs has developed Lentiviral CAR vector pCDCAR1 FR1 (HuMov19) h(28OX_), which is constructed for the engineering of T cells to target human FR1. The T cells are genetically modified through transduction with a Lentiviral vector expressing scFv of anti-FR1 antibody linked to a CD28 transmembrane domain/ endodomain and OX40, CD3-zeta signaling domains. And the vector product was designed for the treatment of ovarian cancer.